International Journal of

Respiratory and Pulmonary MedicineISSN: 2378-3516


Case Report Open Access

A Rare Case of Simultaneously Occurring Pulmonary Fungal Infections

William Li, Bhaskara Madhira and Michael Kosters
Int J Respir Pulm Med Volume 4, Issue 1

Abstract: Endemic infections produce a spectrum of illness ranging from being subclinical to severe progressive disseminated diseases with Immuno compromised individuals being increased risk. In those with an apparently non-improving infection, a simultaneously occurring second infectious source should be considered.

PDF   | Full Text  DOI: 10.23937/2378-3516/1410068

Research Article Open Access

A Single Center Review of Pleural Fluid Samples

C Walker, J Mackenzie, J Aust, J Port, D Cooper, S Parker, S Bourke, J Miller, M Weatherhead and A Aujayeb
Int J Respir Pulm Med Volume 4, Issue 1

Abstract: All pleural aspirations done between January 1st 2014 and December 31st 2015 were analyzed for fluid biochemistry, microbe, cytology and final diagnoses (n = 264). Light's criteria were applied wherever possible. The fluid biochemistry, microbiology and cytology results were assimilated from the local electronic results system. The patient diagnosis was taken from clinic letters electronically uploaded to another system called SingleView. Local governance approval was sought and obtained.

PDF   | Full Text  DOI: 10.23937/2378-3516/1410067

Case Report Open Access

Seromucinous Hamartoma Presenting as an Obstructive Endobronchial Mass

Guang-Qian Xiao and Sapna Patel
Int J Respir Pulm Med Volume 4, Issue 1

Abstract: Seromucinous hamartoma is an extremely rare entity that has been described in the sinonasal cavity and nasopharynx. We here present a case of seromucinous hamartoma manifesting as an obstructive endobronchial mass in a 65-year-old male and active smoker, who presented with dyspnea upon prolonged exertion and atelectasis.

PDF   | Full Text  DOI: 10.23937/2378-3516/1410066

Original Research Open Access

Effects of Chest Physical Therapy in Patients with Non-Tuberculous Mycobacteria

Basavaraj Ashwin, Segal Leopoldo, Samuels Jonathan, Feintuch Jeremy, Feintuch Joshua, Alter Kevin, Moffson Daniella, Scott Adrienne, Addrizzo-Harris Doreen, Liu Mengling and Kamelhar David
Int J Respir Pulm Med Volume 4, Issue 1

Abstract: Antibiotic therapy against non-tuberculous mycobacteria (NTM) is prolonged and can be associated with toxicity. We sought to evaluate whether chest physical therapy (PT) was associated with clinical improvement in patients with NTM not receiving anti-mycobacterial pharmacotherapy. A retrospective review of 77 subjects that were followed from June 2006 to September 2014 was performed. Baseline time point was defined as the first positive sputum culture for NTM; symptoms, pulmonary function, and radiology reports were studied. Subjects were followed for up to 24 months and results analyzed at specified time points.

PDF   | Full Text  DOI: 10.23937/2378-3516/1410065

Volume 4
Issue 1